These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5944035)

  • 1. Toxic hepatitis following phenylbutazone therapy.
    Muscat-Baron JM; Freeman DM
    Br J Clin Pract; 1966 Aug; 20(8):437-9. PubMed ID: 5944035
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver damage due to phenylbutazone and chlorpropamide].
    Grottum KA
    Tidsskr Nor Laegeforen; 1966 Aug; 86(16):1096-8. PubMed ID: 5919203
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic hepatitis following the use of phenylbutazone (butazolidan) report of a fatal case.
    ANTREASIAN B; ROTH MI; TAVEL ME
    J Indiana State Med Assoc; 1958 Jun; 51(6):761-5. PubMed ID: 13549760
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphological aspects of hepatitis induced by phenylbutazone derivatives. Observations on two cases.
    Coltorti M; Cuccurullo L; Del Vecchio Blanco C
    Acta Hepatosplenol; 1971; 18(3):206-15. PubMed ID: 5089187
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylbutazone and hepatitis.
    Fowler PD; Woolf D; Alexander S
    Rheumatol Rehabil; 1975 May; 14(2):71-5. PubMed ID: 1145012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoid granulomas associated with phenylbutazone treatment.
    Lebacq EG; Desmet V
    Mt Sinai J Med; 1977; 44(6):778-81. PubMed ID: 145540
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal hepatitis due to phenylbutazone in a child.
    Dhatt PS; Singh H; Gupta HL; Arya RK
    Indian J Pediatr; 1973 Aug; 40(307):293-4. PubMed ID: 4769816
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenylbutazone-induced hepatitis.
    Mayer TR
    Minn Med; 1979 May; 62(5):349-50. PubMed ID: 440260
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple manifestations of intolerance of a combination of anti-inflammatory drugs. Role of phenylbutazone].
    Tolot F; Prost G; Guignot B; Pelletier M
    Sem Hop; 1975 Dec; 51(48):2555-60. PubMed ID: 175502
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis caused by drugs. 5].
    Valerdiz Casasola S; Linares Rodríguez A; Recarte Alvarez J; Rodrigo Sáez L
    Rev Esp Enferm Apar Dig; 1982 Nov; 62(5):431-44. PubMed ID: 6762631
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-induced lesion of the liver].
    Ivlev AS; Polunina TE
    Voen Med Zh; 1987 Jun; (6):60-1. PubMed ID: 3660719
    [No Abstract]   [Full Text] [Related]  

  • 12. [Non-steroidal antirheumatic therapy and the liver].
    Frank O
    Acta Med Austriaca; 1975; 2(4):145-8. PubMed ID: 1224930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal reaction to phenylbutazone in a patient with Reiter's disease.
    Catterall RD
    Br J Vener Dis; 1968 Jun; 44(2):151-3. PubMed ID: 5761019
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatocellular jaundice due to acute phenylbutazone poisoning. (Clinical observations and morphologic findings using the optic and electron microscopes].
    Scuro LA; Naccarato R; Fagiolo V; Previato G; Rizzo A
    Policlinico Prat; 1967 Apr; 74(16):525-37. PubMed ID: 5609885
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphology and pathogenesis of liver injury produced by dihydralazine , propranolol and ketophenylbutazone].
    Kunze KD; Porst H; Tschöpel L
    Zentralbl Allg Pathol; 1985; 130(6):509-18. PubMed ID: 3841742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulomatous liver disease induced by phenylbutazone].
    Anker N; Skovbjerg H
    Ugeskr Laeger; 1975 Dec; 137(51):3038-9. PubMed ID: 1198751
    [No Abstract]   [Full Text] [Related]  

  • 17. [Iatrogenic damage in therapy with phenylbutazone].
    Visintini E
    Minerva Med; 1971 Feb; 62(16):792-6. PubMed ID: 4251443
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and morphological findings on 2 cases of icterus induced by butazolidines].
    Coltorti M; Cuccurullo L; Del Vecchio-Blanco C
    Policlinico Prat; 1970 Mar; 77(10):309-24. PubMed ID: 5436754
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature.
    Benjamin SB; Ishak KG; Zimmerman HJ; Grushka A
    Hepatology; 1981; 1(3):255-63. PubMed ID: 7286906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic cholestasis due to benetazone].
    Krtek V; Chlumský J
    Vnitr Lek; 1979 Feb; 25(2):152-4. PubMed ID: 570757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.